Quebec Government Awards $13.9 million to IRIC for New Drug Development Against Cancer, Other Medical Conditions
from Institute for Research in Immunology and Cancer
The Institute for Research in Immunology and Cancer of the Université de Montreal received an award of $13.9 million from the "Fonds de partenariat pour un Québec innovant et en santé" to develop new drugs against cancer and other medical conditions, in collaboration with Bristol-Myers Squibb and Merck, two biopharmaceutical companies.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063